Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-0853

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71335-0853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350853)

Label Image (Lbl713350853)
This seems to be a prescription label for Valsartan Hctz, a medication to treat high blood pressure. The medication comes in yellow oval tablets labeled L239. The tablet contains 320/25mg of the active ingredients. It is manufactured by Alembic Pharmaceuticals Limited and should be stored at room temperature. The label also includes directions to keep all drugs out of reach of children. The label includes the NDC code and expiration date, but they are unreadable.*
FDA Label Image

Figure 1 (Valsahctz Figur1)

Figure 1 (Valsahctz Figur1)
This is a graph showing the probability of achieving systolic blood pressure below 140 mmHg in week 8, based on different baseline systolic blood pressure measurements. The data appears to be related to the effectiveness of a medication containing vasarian and hydrochlorothiazide. There are some numerical values associated with each baseline blood pressure measurement, but the context for these values is not clear.*
FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Figure 2-3-4 (Valsahctz Figure2 3 4)
This text contains graphs with images depicting the probability of achieving a certain blood pressure rate after eight weeks of treatment with Valsartan and hydrochlorothiazide tablets of different dosages or a placebo. The graphs represent the probability of achieving diastolic or systolic blood pressure below specific values at week 8. The blood pressure rates are measured in mmHg. No further information is available.*
FDA Label Image

Structure (Valsahctz Hctz)

FDA Label Image

Structure (Valsahctz Valsa)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.